Ihuman Total Current Liabilities from 2010 to 2024

IH Stock  USD 1.55  0.09  5.49%   
Ihuman's Total Current Liabilities is increasing with slightly volatile movements from year to year. Total Current Liabilities is predicted to flatten to about 410.5 M. Total Current Liabilities is the total amount of liabilities that Ihuman Inc is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. View All Fundamentals
 
Total Current Liabilities  
First Reported
2010-12-31
Previous Quarter
490.8 M
Current Value
410.5 M
Quarterly Volatility
170.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Ihuman financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ihuman's main balance sheet or income statement drivers, such as Tax Provision of 34.8 M, Depreciation And Amortization of 6 M or Interest Expense of 13.1 M, as well as many indicators such as Price To Sales Ratio of 1.14, Dividend Yield of 0.0117 or PTB Ratio of 1.34. Ihuman financial statements analysis is a perfect complement when working with Ihuman Valuation or Volatility modules.
  
Check out the analysis of Ihuman Correlation against competitors.

Latest Ihuman's Total Current Liabilities Growth Pattern

Below is the plot of the Total Current Liabilities of Ihuman Inc over the last few years. Total Current Liabilities is an item on Ihuman balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Ihuman Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Ihuman's Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ihuman's overall financial position and show how it may be relating to other accounts over time.
Total Current Liabilities10 Years Trend
Slightly volatile
   Total Current Liabilities   
       Timeline  

Ihuman Total Current Liabilities Regression Statistics

Arithmetic Mean241,882,071
Geometric Mean196,128,055
Coefficient Of Variation70.51
Mean Deviation151,340,095
Median122,334,000
Standard Deviation170,549,882
Sample Variance29087.3T
Range438.7M
R-Value0.83
Mean Square Error9976.5T
R-Squared0.68
Significance0.0002
Slope31,482,809
Total Sum of Squares407221.7T

Ihuman Total Current Liabilities History

2024410.5 M
2023490.8 M
2022561.1 M
2021482.9 M
2020399.2 M
2019182.8 M

About Ihuman Financial Statements

Investors use fundamental indicators, such as Ihuman's Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although Ihuman's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Total Current Liabilities490.8 M410.5 M

Currently Active Assets on Macroaxis

Check out the analysis of Ihuman Correlation against competitors.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Hotels, Restaurants & Leisure space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ihuman. If investors know Ihuman will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ihuman listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.40)
Earnings Share
(0.16)
Revenue Per Share
18.263
Quarterly Revenue Growth
(0.11)
Return On Assets
0.0456
The market value of Ihuman Inc is measured differently than its book value, which is the value of Ihuman that is recorded on the company's balance sheet. Investors also form their own opinion of Ihuman's value that differs from its market value or its book value, called intrinsic value, which is Ihuman's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ihuman's market value can be influenced by many factors that don't directly affect Ihuman's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ihuman's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ihuman is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ihuman's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.